PO Q1 2021 - 39

SECTION
TITLE
CONTRACT
RESEARCH

technology to make it more flexible may be more useful to meet
small-batch requirements.
Pellet technology and minitablets are examples of conventional yet
flexible manufacturing technology that have the potential to allow the
delivery of small-batch precision medicine. This is because it is easy to
combine different pellets or minitablets to achieve combinations of
different drugs in different doses and different release rates.
In addition, it is likely that patients will demand ever more control
over their own medication. Packages and devices that communicate
with smart phones or other devices and make it possible to track
dosing and increase compliance may become more common. This
will make it even more important for drug companies to keep userfriendliness and drug dosage innovation front of mind during the
development stage.

Harnessing the Power of
Outsourced Support
Adapting to an ever-changing pharma landscape is a challenge for
drug companies of all shapes and sizes. In order to stay ahead of the
curve, they need expert support and the capacity to deliver cuttingedge drugs in the right dosage forms to meet the needs of patients
and medical professionals.
Advanced contract development and manufacturing organizations
(CDMOs) are on hand to provide this expert insight and support.
Outsourcing dosage form development to these partners can play a
key role in delivering ever more effective and user-friendly drugs that
meet the market challenges of the future.
Outsourcing partners can provide customers with access to more
technology and competence for dosage form development both
pharmoutsourcing.com |

39

locally and globally. As well as accessing technical capabilities and a
global manufacturing network, pharma companies can also access
years of development and formulation expertise that can help deliver
vital dosage form innovation to meet changing market needs.
CDMOs also offer drug companies greater flexibility and by partnering
with a CDMO that offers both development and commercial
manufacturing services, customers can benefit from integrated
support for their molecules from concept to market, reducing supply
chain complexity, timelines and ensuring smoother progress of a
drug to market.

Staying Ahead in A Fast-Changing Market
The pharmaceutical industry is changing fast. Innovation is becoming
ever more important for pharmaceutical companies, as they strive to
compete with rivals to deliver the most effective treatments to the
market. The dosage form chosen for a drug has a key part to play
here, due to its vital role in useability and user experience and well as
therapeutic effect.
Whatever the future holds for the pharma industry, it is vital that
companies have access to the expert support and capabilities they
need to adapt to changing market needs.
By working with expert CDMO partners, they can ensure they have
the guidance they need to meet new market challenges. In doing so,
they can continue to thrive well into the future.
Torkel Gren is Senior Director, Technology Officer & Strategic Investments at
Recipharm AB. He holds degrees in Pharmacy and Business Administration
as well a PhD in Pharmaceutics (Uppsala University). He has worked in the
pharmaceutical industry since 1988 and has held a number of scientist and
manager positions in Europe and the US. He was lead formulator and coinventor of Detrol OD/Detrusitol SR. Gren is vice chairman of the board of the
Swedish Pharmaceutical Society.
| January/February/March 2021



http://www.pharmoutsourcing.com

PO Q1 2021

Table of Contents for the Digital Edition of PO Q1 2021

PO Q1 2021 - Cover1
PO Q1 2021 - Cover2
PO Q1 2021 - 1
PO Q1 2021 - 2
PO Q1 2021 - 3
PO Q1 2021 - 4
PO Q1 2021 - 5
PO Q1 2021 - 6
PO Q1 2021 - 7
PO Q1 2021 - 8
PO Q1 2021 - 9
PO Q1 2021 - 10
PO Q1 2021 - 11
PO Q1 2021 - 12
PO Q1 2021 - 13
PO Q1 2021 - 14
PO Q1 2021 - 15
PO Q1 2021 - 16
PO Q1 2021 - 17
PO Q1 2021 - 18
PO Q1 2021 - 19
PO Q1 2021 - 20
PO Q1 2021 - 21
PO Q1 2021 - 22
PO Q1 2021 - 23
PO Q1 2021 - 24
PO Q1 2021 - 25
PO Q1 2021 - 26
PO Q1 2021 - 27
PO Q1 2021 - 28
PO Q1 2021 - 29
PO Q1 2021 - 30
PO Q1 2021 - 31
PO Q1 2021 - 32
PO Q1 2021 - 33
PO Q1 2021 - 34
PO Q1 2021 - 35
PO Q1 2021 - 36
PO Q1 2021 - 37
PO Q1 2021 - 38
PO Q1 2021 - 39
PO Q1 2021 - 40
PO Q1 2021 - 41
PO Q1 2021 - 42
PO Q1 2021 - 43
PO Q1 2021 - 44
PO Q1 2021 - 45
PO Q1 2021 - 46
PO Q1 2021 - 47
PO Q1 2021 - 48
PO Q1 2021 - Cover3
PO Q1 2021 - Cover4
https://www.nxtbookmedia.com